{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:43:40Z","timestamp":1762004620851},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":342,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1002\/pds.3710","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T09:02:29Z","timestamp":1411549349000},"page":"52-58","source":"Crossref","is-referenced-by-count":19,"title":["The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network"],"prefix":"10.1002","volume":"24","author":[{"given":"Luc\u00eda","family":"Cea Soriano","sequence":"first","affiliation":[{"name":"Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari-Ann","family":"Wallander","sequence":"additional","affiliation":[{"name":"Department of Public Health and Caring Science; Uppsala University; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Andersson","sequence":"additional","affiliation":[{"name":"Global Epidemiology; Bayer Pharma AG; Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Filonenko","sequence":"additional","affiliation":[{"name":"Global Health Economics and Outcomes Research; Bayer Pharma AG; Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,24]]},"reference":[{"key":"10.1002\/pds.3710-BIB0001|pds3710-cit-0001","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pds.3710-BIB0002|pds3710-cit-0002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1471-0528.12465","article-title":"Use of prescription contraceptive methods in the UK general population: a primary care study","volume":"121","author":"Cea Soriano","year":"2013","journal-title":"BJOG"},{"key":"10.1002\/pds.3710-BIB0003|pds3710-cit-0003","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1002\/pds.3710-BIB0004|pds3710-cit-0004","unstructured":"Office for National Statistics Opinion Survey Report No. 41 Contraception and Sexual Health 2008-09 http:\/\/www.ons.gov.uk\/ons\/search\/index.html?&newquery=Contraception+and+Sexual++Health+Report&pageSize=100&applyFilters=true&sortBy=content-type&sortDirection=ASCENDING"},{"key":"10.1002\/pds.3710-BIB0005|pds3710-cit-0005","unstructured":"National Collaborating Centre for Women's and Children's Health NICE Guidelines Long Acting Reversible Contraception 2005 http:\/\/www.nice.org.uk\/nicemedia\/live\/10974\/29912\/29912.pdf"},{"key":"10.1002\/pds.3710-BIB0006|pds3710-cit-0006","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2011.10.002","article-title":"Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception","volume":"85","author":"Cameron","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/pds.3710-BIB0007|pds3710-cit-0007","first-page":"9","article-title":"Seven years clinical experience of the injectable contraceptive, norethisterone oenanthate","volume":"11","author":"Howard","year":"1985","journal-title":"Brit J Family Planning"},{"key":"10.1002\/pds.3710-BIB0008|pds3710-cit-0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1783\/147118902101196225","article-title":"Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report","volume":"28","author":"Cox","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0009|pds3710-cit-0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1783\/147118902101196216","article-title":"Clinical performance of the Nova T380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report","volume":"28","author":"Cox","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0010|pds3710-cit-0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1783\/147118905774480581","article-title":"An assessment of the first 3 years' use of Implanon in Luton","volume":"31","author":"Agrawal","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0011|pds3710-cit-0011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.contraception.2006.05.072","article-title":"Continuation rates of Implanon in the UK: data from an observational study in a clinical setting","volume":"74","author":"Lakha","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/pds.3710-BIB0012|pds3710-cit-0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4755-10-7","article-title":"Current methods and attitudes of women towards contraception in Europe and America","volume":"10","author":"Johnson","year":"2013","journal-title":"Reprod Health"},{"key":"10.1002\/pds.3710-BIB0013|pds3710-cit-0013","unstructured":"National Institute for Health and Clinical Excellence NICE implementation uptake report: Long-acting reversible contraception (LARC) 2010 http:\/\/www.nice.org.uk\/media\/67F\/C5\/UptakeReportCG30LARC.pdf"},{"key":"10.1002\/pds.3710-BIB0014|pds3710-cit-0014","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"10.1002\/pds.3710-BIB0015|pds3710-cit-0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.3710-BIB0016|pds3710-cit-0016","first-page":"75","article-title":"A language of health in action: Read Codes, classifications and groupings","author":"Stuart-Buttle","year":"1996","journal-title":"Proc AMIA Annu Fall Symp"},{"key":"10.1002\/pds.3710-BIB0017|pds3710-cit-0017","unstructured":"First Databank MULTILEX 2012 http:\/\/www.fdbhealth.co.uk\/solutions\/multilex\/"},{"key":"10.1002\/pds.3710-BIB0018|pds3710-cit-0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13625187.2013.852170","article-title":"Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology","volume":"19","author":"Cea Soriano","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0019|pds3710-cit-0019","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.308.6937.1125","article-title":"Widening inequality of health in northern England, 1981-91","volume":"308","author":"Phillimore","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/pds.3710-BIB0020|pds3710-cit-0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0010-7824(86)90004-1","article-title":"A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Said","year":"1986","journal-title":"Contraception"},{"key":"10.1002\/pds.3710-BIB0021|pds3710-cit-0021","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/humrep\/14.4.976","article-title":"A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group","volume":"14","author":"Croxatto","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1002\/pds.3710-BIB0022|pds3710-cit-0022","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dep027","article-title":"Frequency of discontinuation of contraceptive use: results from a French population-based cohort","volume":"24","author":"Moreau","year":"2009","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1002\/pds.3710-BIB0023|pds3710-cit-0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/ejc.6.s1.23.26","article-title":"Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland","volume":"6","author":"Backman","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0024|pds3710-cit-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(83)80002-X","article-title":"Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report","volume":"28","author":"Task Force on Long-Acting Agents for the Regulation of Fertility","year":"1983","journal-title":"Contraception"},{"key":"10.1002\/pds.3710-BIB0025|pds3710-cit-0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/AOG.0b013e3182a91f45","article-title":"Twenty-four-month continuation of reversible contraception","volume":"122","author":"O'Neil-Callahan","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1002\/pds.3710-BIB0026|pds3710-cit-0026","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13625180400017503","article-title":"Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group","volume":"9","author":"Bitzer","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0027|pds3710-cit-0027","article-title":"What is the actual cost of providing the intrauterine system for contraception in a UK community sexual and reproductive health setting?","author":"Cook","year":"2013","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0028|pds3710-cit-0028","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jfprhc-2012-100392","article-title":"Uptake and continuation rates of the intrauterine system in a university student general practice population in the UK","volume":"39","author":"Armitage","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0029|pds3710-cit-0029","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02699200802253706","article-title":"Experience of IUD\/IUS insertions and clinical performance in nulliparous women-a pilot study","volume":"13","author":"Brockmeyer","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0030|pds3710-cit-0030","unstructured":"The NHS Information Centre NHS Contraceptive Services: England 2012\/13 http:\/\/www.hscic.gov.uk\/catalogue\/PUB12548\/nhs-cont-serv-comm-cont-clin-eng-12-13-rep.pdf"},{"key":"10.1002\/pds.3710-BIB0031|pds3710-cit-0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1783\/147118909787072360","article-title":"Use of contraceptive services in Britain: findings from the second National Survey of Sexual Attitudes and Lifestyles (Natsal-2)","volume":"35","author":"French","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0032|pds3710-cit-0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13625187.2013.852170","article-title":"Study of long-acting reversible contraceptive use in a UK primary care database: Validation of methodology","volume":"19","author":"Cea Soriano","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/pds.3710-BIB0033|pds3710-cit-0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1783\/1471189054483780","article-title":"FFPRHC Guidance (July 2005): The use of contraception outside the terms of the product licence","volume":"31","author":"Penney","year":"2005","journal-title":"J Fam Plann Reprod Health Care"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3710","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T05:55:05Z","timestamp":1565848505000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pds.3710"}},"subtitle":["CONTINUATION RATES OF LARCS IN UK GENERAL PRACTICE"],"short-title":[],"issued":{"date-parts":[[2014,9,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3710","relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,24]]}}}